Abstract:Retinoic X receptor (RXR) is a master nuclear receptor in the processes of cell development and homeostasis. Unliganded RXR exists in an autorepressed tetramer, and agonists can induce RXR dimerization and coactivator recruitment for activation. However, the molecular mechanisms involving the corepressor recruitment and antagonist-mediated repression of RXR are still elusive. Here we report the crystal structure of RXRα ligand-binding domain (LBD) complexed with silencing mediator for retinoid and thyroid hormone receptors (SMRT) corepressor motif. As the first structural report on the unliganded nuclear receptor bound to the corepressor motif, RXRαLBD-SMRT exhibits a significant structural rearrangement, compared with apoRXRαLBD tetramer. To elucidate further the molecular determinants for RXR repression by its antagonist, we also determine the crystal structure of RXRαLBD-SMRT complexed with the identified antagonist rhein. In the structure, two rhein molecules and two SMRT peptides are in the RXRαLBD tetramer, different from the case in RXRαLBD-SMRT structure, where four SMRT peptides bind to RXRαLBD tetramer. It seems that rhein induces a displacement of SMRT motif by activation function 2 (AF-2) motif binding to the receptor. Combining our current work with the published results, structural superposition of RXRαLBDs in different states reveals that RXR uses an overlapped binding site for coactivator, corepressor, and AF-2 motifs, whereas the AF-2 motif adopts different conformations for agonist or antagonist interaction and coactivator or corepressor recruitment. Taken together, we thus propose a molecular model of RXR repression on the tetramer.

Tuning RXR Modulators for PGC1α Recruitment

Ligand-Dependent Coactivation of the Human Bile Acid Receptor FXR by the Peroxisome Proliferator-Activated Receptor Γ Coactivator-1α

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

Distinct Roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in Nuclear Receptor Transactivation.

Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα

Identification of a New RXRα Antagonist Targeting the Coregulator-Binding Site.

Binding Characterization, Synthesis and Biological Evaluation of RXRα Antagonists Targeting the Coactivator Binding Site

Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor

Regulation Of Nt-Pgc-1 Alpha Subcellular Localization And Function By Protein Kinase A-Dependent Modulation Of Nuclear Export By Crm1

Regulation of the Nongenomic Actions of Retinoid X Receptor-Α by Targeting the Coregulator-Binding Sites

Structure-guided design of a highly potent RXR agonist with superior physicochemical properties

Structural basis for the full and partial agonist activities of retinoid X receptor α ligands with an iso-butoxy and an isopropyl group

Integrative Analysis Reveals Structural Basis for Transcription Activation of Nurr1 and Nurr1-RXRα Heterodimer

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

RNA-bound PGC-1α controls gene expression in liquid-like nuclear condensates

Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties

Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA

Simultaneous Substitution of Phenylalanine-305 and Aspartate-318 of Rat Pregnane X Receptor with the Corresponding Human Residues Abolishes the Ability to Transactivate the CYP3A23 Promoter

Ternary Complex of Human RORγ Ligand-Binding Domain, Inverse Agonist and SMRT Peptide Shows a Unique Mechanism of Corepressor Recruitment.

PPARγ phase separates with RXRα at PPREs to regulate target gene expression